Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-Rich Plasma vs Botox for Refractory Overactive Bladder
NCT07184307Completed
- Sponsor
- Benha University
- Start
- Apr 2025
- Primary completion
- Apr 2026
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised trial of platelet-rich plasma in overactive bladder (OAB) (2 arms), sponsored by Benha University. Primary endpoints: Overactive Bladder Symptom Score at 6 months and Maximum Cystometric Capacity at 6 months. Started Apr 2025; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT07184307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07184307.